What is the current valuation of the US lymphedema treatment market as of 2024?

The market valuation was $123.38 Million in 2024. Read More

What is the projected market valuation for the US lymphedema treatment market in 2035?

The projected valuation for 2035 is $278.0 Million. Read More

What is the expected CAGR for the US lymphedema treatment market during the forecast period 2025 - 2035?

The expected CAGR during this period is 7.67%. Read More

Which companies are considered key players in the US lymphedema treatment market?

Key players include Medi USA, BSN Medical, Tactile Medical, Lympha Press, Sigvaris, Juzo, Essity, and MediCom. Read More

What are the primary types of lymphedema and their market valuations?

Primary lymphedema is valued between $40.0 Million and $90.0 Million, while secondary lymphedema ranges from $83.38 Million to $188.0 Million. Read More

Which areas of the body are most affected by lymphedema and what are their market valuations?

Lower extremity lymphedema is valued between $50.0 Million and $113.0 Million, upper extremity between $40.0 Million and $90.0 Million, and genitalia between $33.38 Million and $75.0 Million. Read More

What treatment options are available for lymphedema and their respective market valuations?

Compression devices & bandaging are valued between $40.0 Million and $90.0 Million, laser therapy from $25.0 Million to $60.0 Million, drug therapy from $30.0 Million to $70.0 Million, and surgery from $28.38 Million to $58.0 Million. Read More

Who are the primary end-users of lymphedema treatment products?

Primary end-users include hospitals and clinics, clinical research organizations, and research & academic institutes. Read More

What is the market valuation for hospitals and clinics as end-users in the lymphedema treatment market?

The market valuation for hospitals and clinics as end-users ranges from $50.0 Million to $113.0 Million. Read More

How does the market for lymphedema treatment appear to be evolving in the coming years?

The market appears to be growing steadily, with a projected increase in valuation and a positive CAGR of 7.67% during the forecast period 2025 - 2035. Read More

US Lymphedema Treatment Market

ID: MRFR/HC/49604-HCR

200 Pages

Nidhi Mandole

Last Updated: February 06, 2026

US Lymphedema Treatment Market Research Report By Type (Primary Lymphedema, Secondary Lymphedema), By Affected Area (Lower Extremity, Upper Extremity, Genitalia), By Treatment (Compression Devices & Bandaging, Laser Therapy, Drug Therapy & Surgery), and By End-User (Hospitals and Clinics, Clinical Research Organizations, Research and Academic Institutes) - Growth & Industry Forecast 2025 To 2035

US Lymphedema Treatment Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Type (USD Million)
  1. 4.1.1 Primary Lymphedema
  2. 4.1.2 Secondary Lymphedema
2. 4.2 Medical Device, BY Affected Area (USD Million)
  1. 4.2.1 Lower Extremity
  2. 4.2.2 Upper Extremity
  3. 4.2.3 Genitalia
3. 4.3 Medical Device, BY Treatment (USD Million)
  1. 4.3.1 Compression Devices & Bandaging
  2. 4.3.2 Laser Therapy
  3. 4.3.3 Drug Therapy
  4. 4.3.4 Surgery
4. 4.4 Medical Device, BY End-User (USD Million)
  1. 4.4.1 Hospitals and Clinics
  2. 4.4.2 Clinical Research Organizations
  3. 4.4.3 Research & Academic Institutes
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medi USA (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 BSN Medical (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Tactile Medical (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Lympha Press (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Sigvaris (CH)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Juzo (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Essity (SE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 MediCom (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY AFFECTED AREA
4. 6.4 US MARKET ANALYSIS BY TREATMENT
5. 6.5 US MARKET ANALYSIS BY END-USER
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY AFFECTED AREA, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY AFFECTED AREA, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY TREATMENT, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY TREATMENT, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY END-USER, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY END-USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY AFFECTED AREA, 2025-2035 (USD Million)
  3. 7.2.3 BY TREATMENT, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Medical Device Market Segmentation

Medical Device By Type (USD Million, 2025-2035)

Primary Lymphedema
Secondary Lymphedema

Medical Device By Affected Area (USD Million, 2025-2035)

Lower Extremity
Upper Extremity
Genitalia

Medical Device By Treatment (USD Million, 2025-2035)

Compression Devices & Bandaging
Laser Therapy
Drug Therapy
Surgery

Medical Device By End-User (USD Million, 2025-2035)

Hospitals and Clinics
Clinical Research Organizations
Research & Academic Institutes

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”